Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

Cash and cash equivalents amounted to EUR 550.9 million at the end of September 2024, increasing from EUR 402.5 million at the end of 2023. The ...

CureVac NV (CVAC) reports robust revenue growth and strategic advancements in oncology, despite ongoing litigation challenges.

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

During his time at GSK, Williams was charged with developing business strategies, managing operations and driving sales for vaccines and therapeutics globally, helping to launch over 15 vaccines and ...

Medical experts have called for more health-care resources and education targeting women, children and the elderly during the ongoing China International Import Expo.There are 220 million children und ...

Jefferies lowered GSK (NYSE:GSK) to hold, citing a valuation disconnect between fundamentals and price. Jefferies said it ...

From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...